Investor profile
Avoro Capital Advisors has backed 2 European tech companies across 2 funding rounds between 2021 and 2023, joining rounds totalling €207M. Most active in Healthtech. Data as of 6 Aug 2026.
Also recorded as: Avoro Ventures
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Hemab Therapeutics | Denmark | 1 | €127M |
| Monte Rosa | Switzerland | 1 | €80M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Hemab Therapeutics | Series B | €127M | 2023-02 |
| Monte Rosa | Series C | €80M | 2021-03 |
